Ilex Medical (ILX) - Total Assets
Based on the latest financial reports, Ilex Medical (ILX) holds total assets worth ILA947.26 Million ILA (≈ $2.54 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ILX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Ilex Medical - Total Assets Trend (2008–2024)
This chart illustrates how Ilex Medical's total assets have evolved over time, based on quarterly financial data. See ILX book value for net asset value and shareholders' equity analysis.
Ilex Medical - Asset Composition Analysis
Current Asset Composition (December 2024)
Ilex Medical's total assets of ILA947.26 Million consist of 72.3% current assets and 27.7% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 17.8% |
| Accounts Receivable | ILA249.37 Million | 25.1% |
| Inventory | ILA157.89 Million | 15.9% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA17.08 Million | 1.7% |
| Goodwill | ILA7.00 Million | 0.7% |
Asset Composition Trend (2008–2024)
This chart illustrates how Ilex Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Ilex Medical.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ilex Medical's current assets represent 72.3% of total assets in 2024, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 17.8% of total assets in 2024, down from 25.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.
Ilex Medical Competitors by Total Assets
Key competitors of Ilex Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
Ilex Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.09 | 2.62 | 2.01 |
| Quick Ratio | 2.39 | 2.00 | 1.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA456.84 Million | ILA439.84 Million | ILA269.99 Million |
Ilex Medical - Advanced Valuation Insights
This section examines the relationship between Ilex Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -2.2% |
| Total Assets | ILA994.07 Million |
| Market Capitalization | $147.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ilex Medical's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Ilex Medical's assets decreased by 2.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Ilex Medical (2008–2024)
The table below shows the annual total assets of Ilex Medical from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA994.07 Million ≈ $2.67 Million |
-2.17% |
| 2023-12-31 | ILA1.02 Billion ≈ $2.72 Million |
+13.00% |
| 2022-12-31 | ILA899.18 Million ≈ $2.41 Million |
+2.76% |
| 2021-12-31 | ILA875.07 Million ≈ $2.35 Million |
+12.30% |
| 2020-12-31 | ILA779.25 Million ≈ $2.09 Million |
+33.93% |
| 2019-12-31 | ILA581.85 Million ≈ $1.56 Million |
+9.09% |
| 2018-12-31 | ILA533.38 Million ≈ $1.43 Million |
+9.99% |
| 2017-12-31 | ILA484.92 Million ≈ $1.30 Million |
-0.54% |
| 2016-12-31 | ILA487.56 Million ≈ $1.31 Million |
+1.24% |
| 2015-12-31 | ILA481.60 Million ≈ $1.29 Million |
-4.92% |
| 2014-12-31 | ILA506.54 Million ≈ $1.36 Million |
-5.24% |
| 2013-12-31 | ILA534.54 Million ≈ $1.43 Million |
-11.01% |
| 2012-12-31 | ILA600.69 Million ≈ $1.61 Million |
-12.59% |
| 2011-12-31 | ILA687.23 Million ≈ $1.84 Million |
+258.65% |
| 2010-12-31 | ILA191.62 Million ≈ $513.72K |
-0.67% |
| 2009-12-31 | ILA192.91 Million ≈ $517.19K |
+13.39% |
| 2008-12-31 | ILA170.14 Million ≈ $456.13K |
-- |
About Ilex Medical
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine micros… Read more